Adana Llanos, PhD, MPH confronts the racial inequities in breast cancer, unveiling the hidden impacts of chemical exposures from personal care products.
Sharon Howell had an encouraging response as a patient in the I-SPY clinical trials, and the outcome could also translate to a lower likelihood of her cancer coming back in the future.
Desiree Walker is dedicated to patient advocacy, driving awareness, community outreach engagement, empowering cancer patients, and linking them to the resources they need during treatment and beyond.
The 2021 Real-World Data Impact Award will support the researchers' work into the toxicity and efficacy of oral anticancer drugs and identifying disparities in care.
The 2021 Giants of Cancer Care inductees are leading researchers and educators whose discoveries have propelled the field of oncology forward and established the building blocks for future advances.
The biological reasons for racial disparities in breast cancer still aren’t fully understood, but a new study highlights a prognostic biomarker called Kaiso that may provide some insight.
Patient advocates and members of the Patient Advocacy Board at the HICCC work to ensure that the patient perspective is a priority when it comes to treatment, care, and research.
The National Accreditation Program for Breast Centers (NAPBC) has re-awarded three-year accreditation to the breast center NewYork-Presbyterian/Columbia University Irving Medical Center.
In breast cancer, a building body of research has revealed multitude of cancer care disparities, and patients who are among the minority underserved demographic are hit the hardest.